Your browser doesn't support javascript.
loading
Au@109Pd core-shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of 109Pd/109mAg in vivo generator in combined ß- auger electron therapy.
Gharibkandi, Nasrin Abbasi; Wawrowicz, Kamil; Majkowska-Pilip, Agnieszka; Zelechowska-Matysiak, Kinga; Wierzbicki, Mateusz; Bilewicz, Aleksander.
Afiliação
  • Gharibkandi NA; Centre of Radiochemistry and Nuclear Chemistry, Institute of Nuclear Chemistry and Technology, Dorodna 16 St., 03-195, Warsaw, Poland.
  • Wawrowicz K; Centre of Radiochemistry and Nuclear Chemistry, Institute of Nuclear Chemistry and Technology, Dorodna 16 St., 03-195, Warsaw, Poland.
  • Majkowska-Pilip A; Center for Theranostics, Jagiellonian University, Kopernika 40 St., 31-501, Cracow, Poland.
  • Zelechowska-Matysiak K; Centre of Radiochemistry and Nuclear Chemistry, Institute of Nuclear Chemistry and Technology, Dorodna 16 St., 03-195, Warsaw, Poland.
  • Wierzbicki M; Department of Nuclear Medicine, Central Clinical Hospital of the Ministry of the Interior and Administration, Woloska 137 St., Warsaw, 02-507, Poland.
  • Bilewicz A; Centre of Radiochemistry and Nuclear Chemistry, Institute of Nuclear Chemistry and Technology, Dorodna 16 St., 03-195, Warsaw, Poland.
EJNMMI Radiopharm Chem ; 8(1): 26, 2023 Oct 11.
Article em En | MEDLINE | ID: mdl-37821747
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: EJNMMI Radiopharm Chem Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: EJNMMI Radiopharm Chem Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia